Research progress on the histological scoring system for nonalcoholic fatty liver disease.
10.3760/cma.j.cn501113-20230522-00231
- Author:
Jiao LI
1
;
Qiao Yun GE
1
;
Qi Yuan SONG
1
;
Zhi Hong ZHANG
1
Author Information
1. Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
- Publication Type:Journal Article
- Keywords:
Diagnosis;
Fatty liver disease;
Scoring system
- MeSH:
Humans;
Child;
Non-alcoholic Fatty Liver Disease/pathology*;
Liver/pathology*;
Severity of Illness Index;
Biopsy;
Fibrosis
- From:
Chinese Journal of Hepatology
2023;31(7):765-769
- CountryChina
- Language:Chinese
-
Abstract:
Non-alcoholic fatty liver disease (NAFLD) has replaced chronic hepatitis B as the most common chronic liver disease in China and has now been renamed metabolic dysfunction-associated fatty liver disease (MAFLD). The Brunt, the American NASH Clinical Research Network (NASH-CRN), the European Steatosis, Activity, and Fibrosis/Fatty Liver Inhibition of Progression (SAF/FLIP), and the Pediatric NAFLD are currently the four semi-quantitative grading systems for histological evaluation. This paper reviews these four scoring systems for the clinical selection of appropriate systems for diagnosis and prognosis assessment. This article is a review, and in order to coordinate the evaluation criteria of various scoring systems, the old name "NAFLD" is used.
